Safety information covering side effects, contraindications, drug interactions, and emergency protocols
BPC-157 is sold strictly for laboratory research use only and is not intended for human consumption, medical use, or therapeutic application
Yes, the dosage and frequency of B12 injections are highly dependent on the severity of the deficiency and the presence of neurological symptoms
Outcome measures include neurological severity scoring, rotarod and beam walk performance, histological assessment of lesion volume, and immunohistochemistry for axonal markers and myelin basic protein
Development & validation of LC-MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: Application to pharmacokinetic and oral bioavailability studies (in Eng)